559327548	559327548	CD	B-NP	O
|	|	NN	I-NP	O
DMH	DMH	NN	I-NP	O
|	|	NN	I-NP	O
64379841	64379841	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
039800	039800	CD	B-NP	O
|	|	CC	I-NP	O
11/22/1992	11/22/1992	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/5/1992	11/5/1992	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/1992	10/24/1992	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Sleep	Sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
recently	recently	RB	B-NP	O
diagnosed	diagnose	VBN	I-NP	O
sleep	sleep	JJ	I-NP	O
apnea	apnea	NN	I-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1981	1981	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
DVT	DVT	NN	I-NP	O
which	which	WDT	B-NP	O
required	require	VBD	B-VP	O
IVC	IVC	NN	B-NP	O
filter	filter	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1983	1983	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
nonQ-wave	nonQ-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
and	and	CC	I-NP	O
cath	cath	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
treated	treat	VBN	B-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1991	1991	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
four	four	CD	B-NP	O
minutes	minute	NNS	I-NP	O
in	in	IN	B-PP	O
28	28	CD	B-NP	O
seconds	second	NNS	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

PFT	PFT	NN	B-NP	O
's	'	VBZ	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
reportedly	reportedly	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
details	detail	NNS	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
available	available	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1991	1991	CD	B-NP	O
,	,	,	O	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
included	include	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
normal	normal	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
probable	probable	JJ	I-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	I-NP	O
inhalers	inhaler	NNS	I-NP	O
-LRB-	-LRB-	NNP	B-NP	O
Bronchosol	Bronchosol	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
1991	1991	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
Jeanes	Jeanes	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
Cath	Cath	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1991	1991	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
``	``	``	O	O
asthma	asthma	NN	B-NP	O
''	''	''	O	O
/	/	SYM	B-NP	O
COPD	COPD	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
another	another	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
MI	MI	NN	B-NP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
another	another	DT	B-NP	O
ETT	ETT	NN	I-NP	B-protein
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
four	four	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
45	45	CD	B-NP	O
seconds	second	NNS	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
chest	chest	VB	I-VP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-ADJP	O
.	.	.	O	O

Thallium	Thallium	NN	B-NP	O
showed	show	VBD	B-VP	O
fixed	fix	VBN	B-NP	O
anterior	anterior	JJ	I-NP	O
defects	defect	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	B-protein
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
overlying	overlie	VBG	B-VP	O
breast	breast	NN	B-NP	O
tissue	tissue	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Bronchoscopy	Bronchoscopy	NNP	B-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
been	be	VBN	I-VP	O
tapered	taper	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
11	11	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
sleeps	sleep	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	O	O
occasionally	occasionally	RB	B-VP	O
has	have	VBZ	I-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
-LRB-	-LRB-	DT	B-NP	O
January	January	NNP	I-NP	O
1992	1992	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
1.76	1.76	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
ratio	ratio	NN	B-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
DLCO	DLCO	NN	B-NP	O
of	of	IN	B-PP	O
28.3	28.3	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
twenty-four	twenty-four	CD	I-NP	O
holter	holter	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
arrhythmias	arrhythmia	NNS	B-NP	O
.	.	.	O	O

Exercise	Exercise	NN	B-NP	O
test	test	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
nine	nine	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Thallium	Thallium	NN	B-NP	O
images	image	NNS	I-NP	O
were	be	VBD	B-VP	O
again	again	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

One	One	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
including	include	VBG	B-PP	O
sneezing	sneezing	NN	B-NP	O
,	,	,	O	O
rhinorrhea	rhinorrhea	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Steroids	Steroid	NNS	B-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
as	as	IN	B-SBAR	O
were	be	VBD	B-VP	O
nebulizers	nebulizer	NNS	B-NP	O
with	with	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
wheezing	wheeze	VBG	B-VP	O
worse	worse	JJR	B-ADJP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
sweats	sweat	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
or	or	CC	O	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
marked	marked	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
nebulizer	nebulizer	NN	B-NP	O
and	and	CC	O	O
begun	begin	VBN	B-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Solu	Solu	NN	I-NP	O
-	-	HYPH	B-NP	O
Medrol	Medrol	NN	I-NP	O
.	.	.	O	O

Peak	Peak	NN	B-NP	O
flow	flow	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
180	180	CD	B-NP	O
.	.	.	O	O

Past	Past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
nonQ-wave	nonQ-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
1983	1983	CD	I-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

Sleep	Sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

Allergic	Allergic	JJ	B-NP	O
rhinitis	rhinitis	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

Benign	Benign	JJ	B-NP	O
breast	breast	NN	I-NP	O
cyst	cyst	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
labyrinthitis	labyrinthitis	NN	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
Sjogren	Sjogren	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
anti	anti	JJ	I-NP	I-protein
DNA	DNA	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
1983	1983	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
has	have	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
swollen	swell	VBN	I-VP	O
mouth	mouth	NN	B-NP	O
,	,	,	O	O
Theophylline	Theophylline	NN	B-NP	O
causes	cause	VBZ	B-VP	O
jitteriness	jitteriness	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Kay-Ciel	Kay-Ciel	NN	B-NP	O
8	8	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Prednisone	Prednisone	NN	B-NP	O
11	11	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Guanfacine	Guanfacine	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Verapamil	Verapamil	NN	B-NP	O
240	240	CD	I-NP	O
SR	SR	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
q.d.	q.d.	NN	I-NP	O
if	if	IN	B-SBAR	O
feels	feel	NNS	B-NP	O
okay	okay	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Cromolyn	Cromolyn	NN	B-NP	O
nebs	neb	NNS	I-NP	O
q.	q.	VBP	B-VP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
rarely	rarely	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
;	;	:	O	O
Nasobid	Nasobid	NNP	B-NP	O
inhaler	inhaler	NNP	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Ranitidine	Ranitidine	NN	B-NP	B-protein
q.	q.	NN	I-NP	I-protein
h.s.	h.s.	NN	I-NP	I-protein
HABITS	HABITS	NNS	I-NP	I-protein
:	:	:	O	O
Tobacco	Tobacco	NN	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
rare	rare	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Obese	Obese	NNP	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
initially	initially	RB	B-ADVP	O
but	but	CC	O	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
nebs	neb	NNS	B-NP	O
and	and	CC	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

Otopharynx	Otopharynx	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
thrush	thrush	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
very	very	RB	B-ADJP	O
distant	distant	JJ	I-ADJP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
,	,	,	O	O
scant	scant	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
marked	marked	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
visible	visible	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Grossly	Grossly	RB	B-ADVP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Potassium	Potassium	NN	B-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
16	16	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
15.1	15.1	NN	I-NP	O
,	,	,	O	O
urinalysis	urinalysis	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
X-ray	X-ray	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
disease	disease	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
nebulizers	nebulizer	NNS	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
did	do	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
trigger	trigger	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
remains	remain	VBZ	B-VP	O
illusive	illusive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
esophageal	esophageal	JJ	I-NP	O
acid	acid	NN	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
subclinical	subclinical	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
results	result	NNS	I-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
detected	detect	VBN	B-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
preceding	precede	VBG	B-VP	O
viral	viral	JJ	B-NP	O
illness	illness	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
Heparin	Heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
risks	risk	NNS	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
four	four	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
peak	peak	NN	I-NP	O
flows	flow	NNS	I-NP	O
were	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
500	500	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
had	have	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
remarkably	remarkably	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Foflotroy	Foflotroy	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Atrovent	Atrovent	NNP	B-NP	O
puffers	puffer	VBZ	B-VP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
;	;	:	O	O
Beconase	Beconase	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
inhaler	inhaler	NN	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.	q.	RB	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
;	;	:	O	O
Heparin	Heparin	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Pepcid	Pepcid	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
;	;	:	O	O
Prednisone	Prednisone	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
d.	d.	FW	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-PP	O
tolerated	tolerate	VBN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
nebulized	nebulize	VBD	B-VP	O
treatments	treatment	NNS	B-NP	O
q.	q.	VB	B-VP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Verapamil	Verapamil	NN	B-NP	O
SR	SR	NN	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
Beclovent	Beclovent	NNP	B-NP	O
neb	neb	NN	I-NP	O
six	six	CD	B-NP	O
puffs	puff	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
:	:	:	O	O
Regarding	Regard	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
esophagram	esophagram	NN	I-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
48-hour	48-hour	JJ	I-NP	O
esophageal	esophageal	JJ	I-NP	O
pH	pH	NN	I-NP	O
monitor	monitor	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
reflux	reflux	NN	B-NP	O
episodes	episode	NNS	I-NP	O
and	and	CC	I-NP	O
parameters	parameter	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
4/7	4/7	CD	B-NP	O
cough	cough	NN	I-NP	O
episodes	episode	NNS	I-NP	O
are	be	VBP	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
asthma	asthma	NN	I-NP	O
flares	flare	NNS	I-NP	O
are	be	VBP	B-VP	O
possibly	possibly	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
reflux	reflux	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
completely	completely	RB	B-ADJP	O
diagnostic	diagnostic	JJ	I-ADJP	O
.	.	.	O	O

Benefit	Benefit	NN	B-NP	O
from	from	IN	B-PP	O
anti-reflux	anti-reflux	JJ	B-NP	O
medications	medication	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Reglan	Reglan	NN	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
consider	consider	VB	I-VP	O
further	further	JJ	B-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
studies	study	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
manometry	manometry	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
TREY	TREY	NNP	B-NP	O
BOGHOSIAN	BOGHOSIAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HAACK	HAACK	NNP	I-NP	O
,	,	,	O	O
EMIL	EMIL	NNP	B-NP	O
D.	D.	NNP	I-NP	O
KJ001/8881	KJ001/8881	NN	I-NP	O
/	/	SYM	B-NP	O
RAFAEL	RAFAEL	NN	I-NP	O
EDUARDO	EDUARDO	NNP	I-NP	O
AVERETT	AVERETT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AY1	AY1	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/12/28	5/12/28	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/6/92	8/6/92	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
P402	P402	NN	B-NP	B-protein
Report	Report	NN	I-NP	O
:	:	:	O	O
CX780L2	CX780L2	NN	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O

